Most recent update: Wednesday, April 1, 2020 - 08:35

Bariatric News - Cookies & privacy policy

You are here

Arena Pharmaceuticals


Arena Pharmaceuticals are a biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, or GPCRs, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

In June 2012, the US Food and Drug Administration (FDA) approved Arena's internally discovered and developed drug, BELVIQ. Arena are also seeking regulatory approval for lorcaserin in the European Union, and intend to seek regulatory approval for lorcaserin in additional territories. Regulatory agencies outside the US will independently review lorcaserin.